These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3733389)

  • 21. Management of malignant melanoma: best practices.
    Smylie M; Claveau J; Alanen K; Taillefer R; George R; Wong R; Mason WP;
    J Cutan Med Surg; 2009; 13(2):55-73. PubMed ID: 19459245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma and its therapy: a review.
    Chanda JJ; Callen JP; Stawiski MA
    Cutis; 1979 Jun; 23(6):759-83. PubMed ID: 380931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional and systemic strategies for metastatic malignant melanoma.
    Creagan ET
    Mayo Clin Proc; 1989 Jul; 64(7):852-60. PubMed ID: 2475728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant melanoma.
    Moore GE; Gerner RE
    Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
    [No Abstract]   [Full Text] [Related]  

  • 25. A critical reappraisal of false negative sentinel lymph node biopsy in melanoma.
    Manca G; Romanini A; Rubello D; Mazzarri S; Boni G; Chiacchio S; Tredici M; Duce V; Tardelli E; Volterrani D; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):105-13. PubMed ID: 24835287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis, pathology and therapy of malignant melanoma of the skin (author's transl)].
    Kerl H
    Wien Klin Wochenschr; 1976 Jun; 88(12):369-79. PubMed ID: 782045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of cutaneous melanoma: a practical guide.
    Zalaudek I; Ferrara G; Argenziano G; Ruocco V; Soyer HP
    Skinmed; 2003; 2(1):20-31; quiz 32-3. PubMed ID: 14673321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.
    Batliwalla FM; Bateman BA; Serrano D; Murray D; Macphail S; Maino VC; Ansel JC; Gregersen PK; Armstrong CA
    Mol Med; 1998 Dec; 4(12):783-94. PubMed ID: 9990864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
    Straatsma BR; Nusinowitz S; Young TA; Gordon LK; Chun MW; Rosen C; Seja E; Economou JS; Glaspy JA; Bozon V; Gomez-Navarro J; Ribas A
    Am J Ophthalmol; 2007 Jun; 143(6):958-969. PubMed ID: 17434437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on immunotherapy in melanoma.
    Green J; Ariyan C
    Surg Oncol Clin N Am; 2015 Apr; 24(2):337-46. PubMed ID: 25769716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous melanoma.
    Thompson JF; Scolyer RA; Kefford RF
    Lancet; 2005 Feb 19-25; 365(9460):687-701. PubMed ID: 15721476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in sentinel lymph node mapping for patients with melanoma.
    Brady MS
    Future Oncol; 2012 Feb; 8(2):191-203. PubMed ID: 22335583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of monoclonal antibodies on the study of human malignant melanoma.
    Natali PG; Aguzzi A; Veglia F; Imai K; Burlage RS; Giacomini P; Ferrone S
    J Cutan Pathol; 1983 Dec; 10(6):514-28. PubMed ID: 6198345
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunotherapy of melanoma.
    Smith C; Cerundolo V
    Immunology; 2001 Sep; 104(1):1-7. PubMed ID: 11576213
    [No Abstract]   [Full Text] [Related]  

  • 35. [The latest diagnostical methods and therapy in melanoma].
    Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
    Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-recognition and tumor response to immunotherapy.
    Ernstoff MS
    J Clin Oncol; 2005 Sep; 23(25):5875-7. PubMed ID: 16087939
    [No Abstract]   [Full Text] [Related]  

  • 37. Your patient with melanoma: staging, prognosis, and treatment.
    Rubin KM; Lawrence DP
    Oncology (Williston Park); 2009 Jul; 23(8 Suppl):13-21. PubMed ID: 19860037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunotherapy for melanoma: how can tolerance be overcome?].
    Robert C
    Ann Dermatol Venereol; 2001; 128(6-7):709-13. PubMed ID: 11460031
    [No Abstract]   [Full Text] [Related]  

  • 39. Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
    Litvak DA; Gupta RK; Yee R; Wanek LA; Ye W; Morton DL
    J Am Coll Surg; 2004 Jan; 198(1):27-35. PubMed ID: 14698308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and planned multicenter trials for patients with primary or metastatic melanoma.
    Sondak VK; Han D; Deneve J; Kudchadkar R
    J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.